Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 75551-75600 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05834764
Pyrotinib in Women With High-risk in Early Stage Breast Cancer
PHASE2
Recruiting
188 participants
Started: Apr 8, 2023 · Completed: Dec 31, 2028
1 condition
2 sponsors
1 location
NCT05441163
ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive Cancers
NA
Recruiting
50 participants
Started: Apr 8, 2023 · Completed: Apr 8, 2028
1 condition
1 sponsor
17 locations
NCT05674799
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
NA
Recruiting
403 participants
Started: Apr 8, 2023 · Completed: May 31, 2028
1 condition
2 sponsors
1 location
NCT05834582
Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer
PHASE2
Recruiting
60 participants
Started: Apr 8, 2023 · Completed: Jun 1, 2026
1 condition
2 sponsors
1 location
NCT05800002
IVUS-guided DES Implantation in Coronary Calcification
NA
Recruiting
864 participants
Started: Apr 7, 2023 · Completed: Mar 30, 2033
1 condition
1 sponsor
1 location
NCT05820425
Local Fields Potentientals of the Subthalamic Nucleus in Patients With Parkinson's Disease
N/A
Recruiting
12 participants
Started: Apr 7, 2023 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT05711446
Double Voiding and Post-transplant UTI
NA
Recruiting
438 participants
Started: Apr 7, 2023 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06252636
Evaluation of the Efficacy and Safety of A2 Milk on Digestion
NA
Active, not recruiting
40 participants
Started: Apr 7, 2023 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT05746182
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
N/A
Recruiting
300 participants
Started: Apr 7, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
3 locations
NCT05782777
Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial
NA
Recruiting
4,310 participants
Started: Apr 7, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05949242
Clinical Outcomes in Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent
NA
Active, not recruiting
80 participants
Started: Apr 7, 2023 · Completed: Oct 31, 2025
1 condition
2 sponsors
4 locations
NCT05970133
Robotic Versus Laparoscopy NOSE for Stage I-III Left-sided Colon Cancer
NA
Recruiting
300 participants
Started: Apr 7, 2023 · Completed: Oct 6, 2025
1 condition
1 sponsor
1 location
NCT05626712
Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
PHASE1/PHASE2
Recruiting
18 participants
Started: Apr 7, 2023 · Completed: Jan 31, 2028
2 conditions
1 sponsor
1 location
NCT05564377
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
PHASE2
Recruiting
2,900 participants
Started: Apr 7, 2023 · Completed: Jul 1, 2030
15 conditions
1 sponsor
459 locations
NCT05746325
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast Cancer
NA
Recruiting
5 participants
Started: Apr 7, 2023 · Completed: Mar 1, 2027
3 conditions
1 sponsor
1 location
NCT06747247
MT1013 Injection for the Treatment of Patients With Secondary Hyperparathyroidism (SHPT) Undergoing Maintenance Dialysis
PHASE2
Recruiting
102 participants
Started: Apr 7, 2023 · Completed: Aug 30, 2025
1 condition
1 sponsor
1 location
NCT05621733
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea
N/A
Recruiting
127 participants
Started: Apr 7, 2023 · Completed: May 9, 2026
1 condition
1 sponsor
11 locations
NCT05413304
Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis
PHASE1
Recruiting
17 participants
Started: Apr 7, 2023 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT05470257
Randomized Control Trial: Elbow Extension Versus Flexion Cast in Proximal Half Both Bone Forearm Fractures
NA
Enrolling by invitation
75 participants
Started: Apr 7, 2023 · Completed: Dec 1, 2025
1 condition
2 sponsors
1 location
NCT05776511
Diagnostic Value of eVOG
NA
Recruiting
150 participants
Started: Apr 7, 2023 · Completed: Apr 1, 2026
3 conditions
1 sponsor
1 location
NCT05754957
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
PHASE3
Recruiting
16,000 participants
Started: Apr 7, 2023 · Completed: Dec 9, 2026
1 condition
2 sponsors
998 locations
NCT06033144
Prevalence of Tapia's Syndrome in Weaning Unit
N/A
Recruiting
247 participants
Started: Apr 7, 2023 · Completed: Apr 7, 2027
1 condition
1 sponsor
1 location
NCT05892328
Watermelon Dose Response Blood Pressure Study
NA
Active, not recruiting
36 participants
Started: Apr 7, 2023 · Completed: Mar 1, 2026
2 conditions
2 sponsors
1 location
NCT05641142
Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
NA
Recruiting
100 participants
Started: Apr 7, 2023 · Completed: Apr 30, 2029
2 conditions
1 sponsor
18 locations
NCT05781659
The Effectiveness and Safety of Ultrasound Elastography Guided Pleural Biopsy in the Differential Diagnosis of Benign and Malignant Pleural Effusion
NA
Recruiting
592 participants
Started: Apr 7, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
9 locations
NCT05705193
Brain-Training Treatment for Long COVID in Older Adults
NA
Recruiting
40 participants
Started: Apr 7, 2023 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT05810428
Artificial Intelligence to Predict Surgical Outcomes and Assess Pain Neuromodulation in Trigeminal Neuralgia Subjects
NA
Recruiting
50 participants
Started: Apr 6, 2023 · Completed: Apr 30, 2026
6 conditions
1 sponsor
1 location
NCT05798780
The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors
NA
Active, not recruiting
40 participants
Started: Apr 6, 2023 · Completed: Jul 31, 2026
4 conditions
1 sponsor
1 location
NCT05746559
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
PHASE3
Active, not recruiting
736 participants
Started: Apr 6, 2023 · Completed: Feb 17, 2027
4 conditions
1 sponsor
172 locations
NCT06975800
Effects of Social Feedback on Intracranial EEG
NA
Recruiting
24 participants
Started: Apr 6, 2023 · Completed: Feb 28, 2028
2 conditions
1 sponsor
1 location
NCT05800366
A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
PHASE2
Active, not recruiting
41 participants
Started: Apr 6, 2023 · Completed: Sep 15, 2029
2 conditions
2 sponsors
3 locations
NCT05986630
Safety and Effectiveness Evaluation of TEOSYAL® TPVM Versus COMPARATOR for the Remodeling of the Lower Face
NA
Active, not recruiting
155 participants
Started: Apr 6, 2023 · Completed: Dec 30, 2026
2 conditions
1 sponsor
1 location
NCT05635799
Virtual Reality Applied to the Evaluation and Rehabilitation of Locomotion - Study of Tolerance in the Lower Limb Amputee
NA
Recruiting
70 participants
Started: Apr 6, 2023 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT05516667
Cohort of Patients with Alzheimer's Disease and Their Families.
N/A
Recruiting
1,000 participants
Started: Apr 6, 2023 · Completed: Jan 1, 2027
1 condition
2 sponsors
4 locations
NCT05802615
Protective Assets Reinforced With Integrated Care and TechnologY (PARITY) Feasibility Trial
NA
Active, not recruiting
60 participants
Started: Apr 6, 2023 · Completed: Jul 31, 2025
2 conditions
1 sponsor
1 location
NCT05819021
Open Label Optimization Study
N/A
Active, not recruiting
1,000 participants
Started: Apr 6, 2023 · Completed: Apr 15, 2027
1 condition
1 sponsor
7 locations
NCT05820776
Tele-rehabilitation in Chronic Respiratory Disease: an Observational Cohort Study
N/A
Recruiting
50 participants
Started: Apr 6, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05589181
High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)
PHASE3
Recruiting
140 participants
Started: Apr 6, 2023 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT05844046
Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients
PHASE2
Recruiting
83 participants
Started: Apr 6, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
3 locations
NCT05995262
Effect of a Pharmacist-led, Collaborative Practice on Clinical Outcomes in Persons with Diabetes
N/A
Active, not recruiting
100 participants
Started: Apr 6, 2023 · Completed: Apr 3, 2025
2 conditions
1 sponsor
1 location
NCT06207526
Delusion Ideation in the Context of Everyday Life
NA
Recruiting
15 participants
Started: Apr 6, 2023 · Completed: Aug 31, 2024
1 condition
3 sponsors
1 location
NCT05754853
A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer
PHASE3
Recruiting
290 participants
Started: Apr 6, 2023 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT06646705
Biochemical Evaluation of Periodontal Effects of Orthodontic Treatment with Aligners
NA
Active, not recruiting
25 participants
Started: Apr 6, 2023 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT05570825
SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer
PHASE2
Recruiting
30 participants
Started: Apr 6, 2023 · Completed: Jul 1, 2028
4 conditions
3 sponsors
1 location
NCT05792098
Percutaneous Dilatational Tracheostomy and Thyroid Isthmus Penetration
NA
Enrolling by invitation
200 participants
Started: Apr 6, 2023 · Completed: Dec 12, 2025
1 condition
2 sponsors
1 location
NCT05837429
Low Volume High Intensity Interval Training in Operated Lung Cancer Patients
NA
Recruiting
40 participants
Started: Apr 6, 2023 · Completed: Apr 6, 2025
2 conditions
2 sponsors
1 location
NCT06076902
Patch Study (Patch-augmented Rotator Cuff Repair)
NA
Recruiting
300 participants
Started: Apr 6, 2023 · Completed: Apr 30, 2027
1 condition
1 sponsor
1 location
NCT05865132
Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction
PHASE2
Recruiting
30 participants
Started: Apr 6, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT05768477
Different Treatments in Chronic Pain Patients.
N/A
Recruiting
1,000 participants
Started: Apr 6, 2023 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT05686642
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
PHASE2
Recruiting
300 participants
Started: Apr 6, 2023 · Completed: Dec 12, 2025
1 condition
1 sponsor
28 locations
Previous
1
More pages
1509
1510
1511
1512
1513
1514
1515
More pages
2369
Next